Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Akero Therapeutics Inc (AKRO)
NASDAQ:AKRO
Holding AKRO?
Track your performance easily
Akero Therapeutics (AKRO) Ownership Overview
3.27% Insiders
25.40% Mutual Funds
44.09% Other Institutional Investors
12.96% ETFs
14.28% Public Companies and
Individual Investors
The ownership structure of Akero Therapeutics (AKRO) stock is a mix of institutional, retail, and individual investors. Approximately 82.45% of the company’s stock is owned by Institutional Investors, 3.27% is owned by Insiders, and 14.28% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Sep 13, 2024 | xxxxxxxxxxxxx | $16677 | |
| Sep 13, 2024 | Andrew Cheng President & Ceo,director | xxxxxxxxxxxxx | $45501 |
| Sep 13, 2024 | xxxxxxxxxxxxx | $14870 | |
| Sep 13, 2024 | xxxxxxxxxxxxx | $16729 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $384331 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $8390906 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $49197784 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,507,363 | Institution | 5.02% | 107,448,066 | |
| 3,157,196 | Institution | 4.52% | 96,720,699 | |
| 2,970,761 | Institution | 4.26% | 91,009,263 | |
| 2,508,425 | Institution | 3.59% | 76,845,600 | |
| 2,321,101 | Institution | 3.33% | 71,106,929 | |
| 1,995,635 | Institution | 2.86% | 61,136,278 | |
| 1,714,806 | Institution | 2.46% | 52,533,082 | |
| 1,097,082 | Institution | 1.57% | 33,609,107 | |
| 1,069,844 | Institution | 1.53% | 32,774,671 | |
| 802,168 | Insider | 1.15% | 24,574,417 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,970,761 | Institution | 4.26% | 91,009,263 | |
| 2,508,425 | Institution | 3.59% | 76,845,600 | |
| 2,321,101 | Institution | 3.33% | 71,106,929 | |
| 1,995,635 | Institution | 2.86% | 61,136,278 | |
| 753,408 | Institution | 1.08% | 23,080,654 | |
| 732,719 | Institution | 1.05% | 22,446,847 | |
| 722,363 | Institution | 1.03% | 22,129,591 | |
| 542,464 | Institution | 0.78% | 16,618,385 | |
| 470,835 | Institution | 0.67% | 14,424,030 | |
| 450,880 | Institution | 0.65% | 13,812,709 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,926,204 | Institution | 2.76% | 59,384,869 | |
| 1,851,642 | Institution | 2.65% | 56,725,053 | |
| 977,048 | Institution | 1.40% | 30,317,799 | |
| 955,892 | Institution | 1.37% | 29,470,150 | |
| 546,176 | Institution | 0.78% | 16,732,102 | |
| 404,150 | Institution | 0.58% | 12,381,135 | |
| 309,075 | Institution | 0.44% | 9,528,782 | |
| 306,540 | Institution | 0.44% | 9,511,936 | |
| 228,454 | Institution | 0.33% | 6,998,688 | |
| 160,953 | Institution | 0.23% | 4,962,181 |
FAQ
Who Owns Akero Therapeutics Inc (AKRO)?
According to the latest TipRanks data, approximately 44.09% of the company's stock is held by institutional investors, 3.27% is held by insiders, and 14.28% is held by retail investors.
What percentage of Akero Therapeutics Inc (AKRO) stock is held by institutional investors?
According to the latest TipRanks data, approximately 44.09% of Akero Therapeutics Inc (AKRO) stock is held by institutional investors.
What percentage of Akero Therapeutics Inc (AKRO) stock is held by retail investors?
According to the latest TipRanks data, approximately 14.28% of Akero Therapeutics Inc (AKRO) stock is held by retail investors.
Who owns the most shares of Akero Therapeutics Inc (AKRO)?
Vanguard owns the most shares of Akero Therapeutics Inc (AKRO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.